A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Aflibercept
Related studies linked through entity extraction aliases.
A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
ADVM-022 Intravitreal Gene Therapy for DME
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE4
Trial to Evaluate the Safety and Tolerability of Repeated Intravitreal Injection of IBI302 in Neovascular AMD Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, and Efficacy of Aflibercept in Patients With Neovascular Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2
Treat and Extend Analysis Trial With Aflibercept in Wet-AMD
- Status
- UNKNOWN
- Phase
- PHASE3
Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME)
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Status
- WITHDRAWN
- Phase
- PHASE3
To Compare Brolucizumab to Aflibercept in Chinese Patients With Visual Impairment Due to Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration.
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- NA
A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification
- Status
- COMPLETED
- Phase
- PHASE4